baber/WOPTO huggingface dataset:
Patent JP-4002614-B2 (JP)
IPC: A61C13/34
Filed: 1997-08-21
Granted: 2007-11-07
Abstract: A dental model articulator includes two hinge-jointed arms, each arm having segments connected at a hinge joint having mating elements, one integral to each segment of an arm. One element includes two cymbals that are coaxial on a major hinge axis and concave facing which resiliently capture between them a node of the mating element on the other segment which has the form of opposed, outwardly facing convexities. Multiaxial motion between the segments of each arm is accommodated by the rotation of the convexities of the node within detents at the apices of the cymbals. The extremities of each arm terminate in cylindrical rod-like elements that are parallel to the major hinge axis. The rods engage with transverse, cylindrical channels either cut-in, molded-in or affixed to the models. With the models positioned in centric occlusal relationship and the arms adjacently positioned and engaged, the four rods are adhesively fixed in the channels. Once fixed, the two hinge joints together define a single hinge axis posterior and interjacent to the models. Further, each hinge joint can allow the node elements to release from the axis detents and slide between the cymbals to permit protrusive and lateral masticatory motions between the dental models.
Patent JP-3011954-B2 (JP)
IPC: C09D177/00
Filed: 1989-10-03
Granted: 2000-02-21
Abstract: Disclosed is a water-dissipatable polyester containing a sulfonate group and at least 10 mole percent of a multifunctional or branch-inducing moiety. The polyester is useful to prepare coatings such as paints.
Patent JP-3830976-B2 (JP)
IPC: C12N5/0793
Filed: 1997-09-12
Granted: 2006-10-11
Abstract: The present invention provides methods for expanding and increasing survival of hematopoietic cell populations, for prolonging viability of an organ for transplantation, and enhancing bioproduction, using interleukin-1 beta -converting enzyme (ICE)/CED-3 family inhibitors. Exemplary compounds useful in the methods of the invention are provided herein.
Patent JP-3832596-B2 (JP)
IPC: B24D3/00
Filed: 1993-03-25
Granted: 2006-10-11
Abstract: Multi-layer coated diamond abrasive particles having improved wear performance in abrasive tools are provided, wherein the coating comprises a single homogenous, carbide forming metal primary layer, preferably of chromium, and at least one non-carbide forming secondary layer applied by electroless deposition, preferably comprised of nickel/phosphorus or cobalt/phosphorus.
Patent JP-3217375-B2 (JP)
IPC: E03D9/00
Filed: 1996-11-12
Granted: 2001-10-09
Abstract: PCT No. PCT/CH96/00398 Sec. 371 Date Dec. 15, 1997 Sec. 102(e) Date Dec. 15, 1997 PCT Filed Nov. 12, 1996 PCT Pub. No. WO97/21002 PCT Pub. Date Jun. 12, 1997The lavatory has a housing in which a dish-like bowl having a seat is pivotably inserted. The bowl can be swivelled from a position of use into a flushing position. Furthermore, a cleaning apparatus which serves for cleaning the seat and the bowl with pressurized water in the flushing position is arranged in the housing. This cleaning apparatus has for this purpose a cover which overlaps the spray nozzles serving for cleaning the bowl and seat. In the flushing position, the cover and the bowl together bound a cleaning space which is sealed fluid-tight from the interior of the housing. During the cleaning process, even contaminants adhering stubbornly to seat surface or inner wall of the bowl are removed by the pressurized water and washed in the direction of the feces drain. After the cleaning with pressurized water, the bowl and the seat are dried with cold or hot air, for which purpose the cleaning apparatus is additionally provided with a fan.
Patent JP-3688300-B2 (JP)
IPC: C08G77/06
Filed: 1997-01-23
Granted: 2005-08-24
Abstract: A method for preparing polyorganosiloxanes by hydrolysing organohalosilanes of formula (I) RaR<1>bSiXc, wherein each of R and R<1>, which are the same or different, is hydrogen or straight or branched C1-6 alkyl, aryl, alkylaryl or aralkyl, X is a halogen, and a + b + c = 4 and 0 < c < 4. The method essentially comprises a series of at least three hydrolysis steps (1, 2, 3) in which the reaction medium is capable of exerting an increasing hydrolysing force on the organohalosilanes (I), and optionally at least one coalescence step (4). Step (1) involves pressure hydrolysis in the presence of a saturated aqueous hydrogen halide solution S1 and at the same temperature and pressure as the reaction medium.
Patent JP-4162717-B2 (JP)
IPC: G01B7/00
Filed: 1997-12-08
Granted: 2008-10-08
Abstract: A differential touch sensor apparatus for detecting the presence of an object such as a human appendage, the apparatus having a first electrode, a second electrode positioned proximate to the first electrode, a differential circuit connected to the first and second electrodes, and a pulse or other signal source connected to provide electrical signals that generate an electric field between the first and second electrodes. Introduction of an object near the first electrode affects the electric field between the first and second electrodes, thereby affecting the voltage difference between them. A differential circuit provides an output signal responsive to the difference in voltage between the first and second electrodes. In an alternative embodiment, a strobe electrode is provided proximate to both said first and second electrodes and the pulses or other signals are provided to the strobe electrode to induce an electric field between the strobe electrode and each of the first and second electrodes.
Patent JP-3409857-B2 (JP)
IPC: A61K35/14
Filed: 1997-12-25
Granted: 2003-05-26
Abstract: A method for activating human antigen presenting cells characterized by culturing in vitro antigen presenting cells with a human origin together with at least one of glycoside compounds represented by general formula (A) or salts thereof preferably exemplified by (2S, 3S, 4R)-1-( alpha -D-galactopyranosyloxy)-2-hexacosanoylamino-3,4-octadecanediol; the human antigen presenting cells thus activated; methods for treating cancer or infectious diseases such as AIDS by using activated human antigen presenting cells; and the use of activated human antigen presenting cells in the production of drugs for treating these diseases. Thus, sufficient therapeutic effects can be achieved on cancer and infectious diseases such as AIDS without effecting any pulse therapy with the use of tumor antigens. <CHEM>
Patent JP-3933200-B2 (JP)
IPC: H02P6/20
Filed: 1996-04-11
Granted: 2007-06-20
Abstract: A surgical system, adapted to operate with at least one surgical device, has a handpiece containing a motor which is adapted to receive the surgical device. The surgical device is driven through a continuum of positions by the motor output shaft. A controller microprocessor controls the operation of the system. The motor has sensors for generating electrical position signals and the controller is responsive to input signals for defining both a stop position and a reversal position for the surgical device. As a result, the controller initiates operation of the surgical device at the so called stop position and stops operation of the surgical device so that it comes to rest substantially at the stop position. In an oscillatory mode of operation, the controller also forces reversals to occur solely at a reversal position dictated by the system, under the control of the user. In connection with an arthroscopic cutting device, the control enables the surgeon to control, for example, the opening of the aperture through which tissue and fluids are removed from the surgical site during the reversal and start/stop conditions.
Patent JP-4614473-B2 (JP)
IPC: C07K14/715
Filed: 1998-01-15
Granted: 2011-01-19
Abstract: Novel proteins IR1B1 and IR1B4 have been isolated which bind to the type I IFN receptor IFNAR1 and function in the cellular response to IFNs. DNA encoding such proteins in either the sense or anti-sense orientation can be administered to either enhance or inhibit the cellular response to IFNs. Antibodies to the proteins can be used for isolation of the new protein or for immunodetection thereof.
Patent JP-3345891-B2 (JP)
IPC: A61K31/495
Filed: 1997-03-19
Granted: 2002-11-18
Abstract: A method for preventing and/or treating heart failure and ventricular dysfunction in a warm blooded animal comprising administering to the warm blooded animal a therapeutically effective amount of an endothelin antagonist of the formula: as defined herein.
Patent JP-3724814-B2 (JP)
IPC: G11B5/64
Filed: 1997-03-28
Granted: 2005-12-07
Abstract: A magnetic recording medium having a high coercive force of a ferromagnetic metal layer, a high anisotropic magnetic field and/or normalized coercive force, and adaptable to high density recording. The magnetic recording medium comprises a substrate body and a ferromagnetic metal layer containing at least Co and Cr formed thereon via a metallic underlying layer of Cr. Magnetic inversion is utilized for the recording. A region (1) which penetrates through the ferromagnetic metal layer and in which Cr is segregated are formed among the crystal grains constituting the ferromagnetic metal layer. The Cr concentration in the intermediate portions of the region (1) in the direction of thickness of the ferromagnetic metal layer is smaller than that of the portions near the surface and near the metallic underlying layer. The crystal grains of the ferromagnetic metal layer are constituted by a region (2) in which the Cr concentration increases toward the grain boundary and a region (3) which is formed at the center of the crystalline particle and whose Cr concentration is lower than that near the grain boundary. The maximum Cr concentration in the region (3)b is smaller than the maximum Cr concentration in the region (2). <IMAGE>
Patent ES-2283218-B2 (ES)
Inventor: RIVERA UTRILLA JOSE
IPC: C02F1/28
Filed: 2006-03-29
Granted: 2008-06-01
Abstract: Adsorbents for removing chlorides, bromides and iodides from water, which are based on silver-cation-doped aerogels. The proposed system is geared principally to the removal of bromide and iodide anions from drinking water and also to obtaining water of high purity.
Patent IE-S86396-B2 (IE)
Title: Valve for central heating and domestic hot water system
Inventor: O'BYRNE MICHAEL
IPC: F16K21/00
Filed: 2013-03-25
Abstract: The present invention relates to a valve for use in central heating and domestic hot water systems, to control the flow of water in the circuits of such systems. In particular the invention provides a valve comprising a valve body and valve actuator, the valve body being of a two or three port variety incorporating a valve closing member attached to a rotary valve stem, the valve actuator having a rotary spindle for interface with the stem of the valve body, the motive force for the rotation of the actuator spindle being the force generated in an SMA member when said member is subjected to a phase changing temperature transition. The advantage of the invention is the product longevity afforded by an SMA based actuator in contrast to the more limited longevity afforded by a motor is based actuator, motor based actuators being particularly vulnerable to motor burn out. <Figure 3b>
Patent IE-S87022-B2 (IE)
Title: Vitamin E acetate intermediates 2,3,5-trimethylbenzoquinone synthesis method
Inventor: FEI PENG
IPC: C07C50/00
Filed: 2018-04-04
Abstract: The present invention discloses vitamin E acetate intermediates 2,3,5-trimethylbenzoquinone synthesis method by 2-methyl-4-hydroxy-3,6-dimethylol toluene, 2,5-hexanediol solution were added to the reaction vessel, controlled the stirring speed, raising the solution temperature, added molybdenum disulfide powder, raised the temperature of the solution, kept for 90-140 min; extracted with N-methylaniline solution for several times, washed with 2-methylpyridine solution for several times, standing for stratification, recrystallized in 3-methyl-2-butanol solution, dehydrated with dehydrating agent, finally got finished product 2, 3,5 -trimethyl benzoquinone. <Figure 1>
Patent AU-2000269903-B2 (AU)
Title: Mechanical connection of panels
Inventor: WEBER JURGEN
IPC: E04F15/04
Filed: 2000-08-01
Granted: 2004-04-22
Abstract: The invention relates to a panel connection, particularly for flooring panels, having a groove (34) that is embodied at a side edge (3); a spring (32) that is embodied at a side edge (4); a depression (35) that is embodied in the groove (34) and has an interlocking surface (16); an interlocking element (33) that is embodied at the spring (32) and has an interlocking surface (27); and fitting surfaces (12, 22), which are embodied in the groove (34) and at the spring (32) and serve as abutments for the interlocking surfaces (17, 27). The properties of interlocking and orientation stability are improved in that the groove (34) has fitting surfaces (14, 15), which extend parallel to the top side (5), in the region of the groove bottom (7), and the spring (32) has fitting surfaces (24, 25), which extend parallel to the top side (9), in the region of the end surface (8), with the fitting surfaces (14, 24; 15, 25) resting against one another in the interlocked state of the connection.
Patent AU-2001233979-B2 (AU)
Title: 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
Inventor: PEARSON STUART ERIC
IPC: C07D521/00
Filed: 2001-02-26
Granted: 2004-11-11
Abstract: Pyrimidine derivatives of formula (I) wherein Q<SUB>1</SUB>, Q<SUB>2</SUB>, G and R<SUP>1 </SUP>are as defined within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described.
Patent AU-2001238468-B2 (AU)
Title: Aspirin-triggered lipid mediators
Inventor: SERHAN CHARLES N
IPC: A61P19/02
Filed: 2001-02-16
Granted: 2006-07-06
Abstract: Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment or prevention of inflammation associated with various diseases, including ischemia.
Patent AU-2003240719-B2 (AU)
Title: Ophthalmological use of roflumilast for the treatment of diseases of the eye
Inventor: LINDER RUDOLF
IPC: A61K47/06
Filed: 2003-05-27
Granted: 2009-12-10
Abstract: A topical pharmaceutical preparation for administering a slightly soluble PDE 4 inhibitor is described. A surprisingly good systemic bioavailability is observed with this dosage form.
Patent AU-2003246071-B2 (AU)
Title: Radio IC tag reader, radio IC tag read apparatus and radio IC tag read system
Inventor: FUKUOKA SHINICHIRO
IPC: H01Q7/00
Filed: 2003-09-12
Granted: 2008-05-22
Abstract: An antenna conducts radio communication with an integrated circuit (IC) tag attached to articles such as books, clothes. A main unit (13) supplies power to the antenna. An antenna sheath (11) houses the antenna and has a flat structure attached to front side of the main unit. An independent claim is also included for radio IC tag read system.
Patent AU-2004231566-B2 (AU)
Title: Shear mode diagnostic ultrasound
Inventor: CLEMENT GREGORY T
IPC: A61N7/00
Filed: 2004-04-12
Granted: 2010-07-15
Abstract: A method of diagnosing a subject by delivering ultrasound signals using shear waves includes applying a portion of an ultrasound mainbeam to a bone surface at an incident angle relative to the surface of the bone to induce shear waves in the bone, energy in the shear waves forming a substantial part of energy of first ultrasound waves at a desired region in the subject through the bone, detecting at least one of reflected and scattered energy of the applied ultrasound mainbeam, and analyzing the detected energy for a diagnostic purpose.
Patent AU-2004312090-B2 (AU)
Title: Pharmaceutical composition for thrombin peptide derivatives
Inventor: HOBSON DAVID W
IPC: A61K31/4745
Filed: 2004-12-30
Granted: 2008-08-14
Abstract: Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above. <IMAGE>
Patent AU-2005238195-B2 (AU)
Title: Process for the production of cyclic diketones
Inventor: EDMUNDS ANDREW
IPC: C07D213/55
Filed: 2005-04-29
Granted: 2011-07-28
Abstract: The present invention relates to a process for the preparation of compounds of formula (I), wherein the substituents are as defined in claim 1, by reacting a compound of formula (II), either with a chlorination or bromination agent or with a compound of formula (III) CI-SOR, R being C-Calkyl, C-Chaloalkyl, phenyl or C-Calkyl-substituted phenyl, to form the compound of formula (IV), reacting the compound of formula (IV) with a compound of formula (V) M-O-C(O)-Y, wherein Y is as defined above and M is the hydrogen cation or an alkali metal ion, alkaline earth metal ion or ammonium ion, to form the compound of formula (VI) and treating that compound with a cyanide source in the presence of a base.
Patent AU-2005247242-B2 (AU)
Title: Method of producing milk drink
Inventor: TAKASHI SUGAWARA
IPC: A23C3/03
Filed: 2005-05-27
Granted: 2011-08-18
Abstract: It is intended to provide a milk drink obtained by starting with a milk protein-containing powder (skim milk powder, etc.) having a seriously worsened flavor which is free from worsening in the flavor after heating and sustains a flavor comparable to a product obtained by starting with fresh milk or fermented milk alone without using such a starting material as described above. An inert gas such as nitrogen gas is bubbled into a conditioned milk liquor containing a milk protein-containing powder (for example, whole milk powder or defatted milk powder) which is obtained by starting with fresh milk or milk so as to lower the dissolved oxygen concentration in the conditioned milk liquor to 8 ppm or below. Next, the conditioned milk liquor is subjected as such to heat sterilization.
Patent AU-2005285037-B2 (AU)
Title: Organosilanes and substrate bonded with same
Inventor: BORDUNOV ANDREI V
IPC: C07F7/18
Filed: 2005-09-09
Granted: 2011-07-21
Abstract: The present invention provides novel silicon compounds, methods for making these novel silicon compounds, compostions comprising these novel silicon compounds attached to substrates, methods for attaching the novel silicon compounds to substrates and methods for using the compositions in a variety of chromatographic applications.
Patent AU-2005330513-B2 (AU)
Title: Location beacon database and server, method of building location beacon database, and location based service using same
Inventor: FARSHID ALIZADEH-SHABDIZ
IPC: H04W4/029
Filed: 2005-10-28
Granted: 2011-07-14
Abstract: A location beacon database and server, method of building location beacon database, and location based service using same. Wi-Fi access points are located in a target geographical area to build a reference database of locations of Wi-Fi access points. At least one vehicle is deployed including at least one scanning device having a GPS device and a Wi-Fi radio device and including a Wi-Fi antenna system. The target area is traversed in a programmatic route to avoid arterial bias. The programmatic route includes substantially all drivable streets in the target geographical area and solves an Eulerian cycle problem of a graph represented by said drivable streets. While traversing the target area, periodically receive the GPS coordinates of the GPS device. While traversing the target area, detecting Wi-Fi signals from Wi-Fi access points in range of the Wi-Fi device and recording identity information of the detected Wi-Fi access point in conjunction with GPS location information of the vehicle when the detection of the Wi-Fi access point was made. The location information is used to reverse triangulate the position of the detected Wi-Fi access point; and the position of the detected access point is recorded in a reference database. A user-device having a Wi-Fi radio may be located. A reference database of calculated locations of Wi-Fi access points in a target area is provided. In response to a user application request to determine a location of a user-device having a Wi-Fi radio, the Wi-Fi device is triggered to transmit a request to all Wi-Fi access points within range of the Wi-Fi device. Messages are received from the Wi-Fi access points within range of the Wi-Fi device, each message identifying the Wi-Fi access point sending the message. The signal strength of the messages received by the Wi-Fi access points is calculated. The reference database is accessed to obtain the calculated locations for the identified Wi-Fi access points. Based on the number of Wi-Fi access points identified via received messages, choosing a corresponding location-determination algorithm from a plurality of location-determination algorithms, said chosen algorithm being suited for the number of identified Wi-Fi access points. The calculated locations for the identified Wi-Fi access points and the signal strengths of said received messages and the chosen location-determination algorithm are used to determine the location of the user-device. The database may be modified with newly added position information to improve quality of previously determined positions, and error prone information is avoided.
Patent AU-2006210513-B2 (AU)
Title: Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
Inventor: TACHDJIAN CATHERINE
IPC: A23L27/26
Filed: 2006-02-06
Granted: 2012-03-15
Abstract: The inventions disclosed herein relate to the discovery of the use of compounds having the formula shown below and certain subgenera or species thereof, as flavor or taste modifiers, particularly, savory ("umami") taste modifiers, savory flavoring agents and savory flavor enhancers in foods, beverages, and other comestible compositions.
Patent AU-2006218944-B2 (AU)
Title: Sprayable coating composition
Inventor: STANDING STEPHEN STUART
IPC: C09D11/10
Filed: 2006-02-16
Granted: 2012-06-14
Abstract: A sprayable energy-curable coating composition comprises an epoxide monomer or oligomer, a cationic photoinitiator and a cyclic carbonate, the cyclic carbonate being present in an amount of at least 7% by weight of the entire composition.
Patent AU-2006253478-B2 (AU)
Title: Test method for endotoxin
Inventor: SHIOZAKI TETSUYA
IPC: G01N33/579
Filed: 2006-05-30
Granted: 2012-03-29
Abstract: Disclosed is a method which can detect an endotoxin derived from a gram negative bacterium in a sample in which it has been difficult to detect or quantify the endotoxin accurately or the like by the method described in the Handbook of the Japanese Pharmacopoeia, 14th ed., Hirokawa Publishing Co., 2001:B-63. A test method for an endotoxin using a lysate reagent comprising the step of adding the lysate reagent to a sample in the presence of albumin and/or globulin and then performing the determination.
Patent AU-2006336451-B2 (AU)
Title: Apparatus and method for reducing fluid drag on a submerged surface
Inventor: STUBBLEFIELD JERRY D
IPC: B63B1/34
Filed: 2006-01-27
Granted: 2012-11-08
Abstract: An apparatus and method for reducing surface friction drag on the hull of a surface vessel by entraining air into water flowing in the boundary layer flow along the hull. The apparatus creates a reduced pressure region by diverting a first portion of the flow away from the surface of the hull. An air pocket is formed in the reduced pressure region and a second portion of the flow is directed through the air pocket by nozzles, which acts as a plunging jet and entrains air into the boundary layer.